99 related articles for article (PubMed ID: 3677786)
1. Effects of benfluorex on patients with endogenous hypertriglyceridaemia.
Ranquin R
Curr Med Res Opin; 1987; 10(8):521-6. PubMed ID: 3677786
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of benfluorex in type II diabetic patients on diet regimen alone.
Velussi M; Monte AD; Cernigoi AM
J Diabetes Complications; 1996; 10(5):261-6. PubMed ID: 8887014
[TBL] [Abstract][Full Text] [Related]
3. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
[TBL] [Abstract][Full Text] [Related]
4. Effects of benfluorex on serum triacylglycerols and insulin sensitivity in the corpulent rat.
Russell JC; Graham SE; Dolphin PJ; Brindley DN
Can J Physiol Pharmacol; 1996 Aug; 74(8):879-86. PubMed ID: 8960376
[TBL] [Abstract][Full Text] [Related]
5. Benfluorex and blood glucose control in non insulin-dependent diabetic patients.
Cavallo-Perin P; Estivi P; Boine L; Galletti R; Pacini G; Cobelli C; Pagano G
J Endocrinol Invest; 1991 Feb; 14(2):109-13. PubMed ID: 2061566
[TBL] [Abstract][Full Text] [Related]
6. Effects of insulin reduction with benfluorex on serum dehydroepiandrosterone (DHEA), DHEA sulfate, and blood pressure in hypertensive middle-aged and elderly men.
Nestler JE; Beer NA; Jakubowicz DJ; Colombo C; Beer RM
J Clin Endocrinol Metab; 1995 Feb; 80(2):700-6. PubMed ID: 7852539
[TBL] [Abstract][Full Text] [Related]
7. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy.
Kissebah AH; Alfarsi S; Adams PW; Seed M; Folkard J; Wynn V
Atherosclerosis; 1976; 24(1-2):199-218. PubMed ID: 182185
[TBL] [Abstract][Full Text] [Related]
8. Metabolic and anti-atherogenic effects of long-term benfluorex in dyslipidemic insulin-resistant sand rats (Psammomys obesus).
Marquié G; El Madani T; Solera ML; Pieraggi MT; Hadjiisky P; Ravel D; Seguin L; Bennani N
Life Sci; 1998; 63(1):65-76. PubMed ID: 9667766
[TBL] [Abstract][Full Text] [Related]
9. Improvement in glucose tolerance of insulin resistant rats after chronic or acute administration of benfluorex.
Lacour F; Espinal J; Arnaud O; Duhault J
Life Sci; 1993; 53(20):1525-9. PubMed ID: 8412519
[TBL] [Abstract][Full Text] [Related]
10. Decreased serum lipids, serum insulin and triacylglycerol synthesis in adipose tissue of JCR:LA-corpulent rats treated with benfluorex.
Brindley DN; Hales P; al-Sieni AI; Russell JC
Biochim Biophys Acta; 1991 Aug; 1085(1):119-25. PubMed ID: 1892872
[TBL] [Abstract][Full Text] [Related]
11. [A new therapeutic approach of associated metabolic diseases. 1 000 patients treated with benfluorex (author's transl)].
Glikmanas M; Giraudet MC; Fould G
Sem Hop; 1979 Sep 8-15; 55(27-30):1305-11. PubMed ID: 228405
[TBL] [Abstract][Full Text] [Related]
12. Added benfluorex in obese insulin-requiring type 2 diabetes.
Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic administration of benfluorex to rats on the metabolism of corticosterone, glucose, triacylglycerols, glycerol and fatty acid.
Brindley DN; Akester H; Derrick GP; Irvine CD; Patmore RD; Spencer H; Yule-Smith A; Finnerty C; Saxton J; Macdonald IA
Biochem Pharmacol; 1988 Feb; 37(4):695-705. PubMed ID: 3342101
[TBL] [Abstract][Full Text] [Related]
14. Benfluorex improves muscle insulin responsiveness in middle-aged rats previously subjected to long-term high-fat feeding.
Sevilla L; Gumà A; Muñoz P; Testar X; Palacín M; Zorzano A
Life Sci; 1999; 64(1):25-36. PubMed ID: 10027739
[TBL] [Abstract][Full Text] [Related]
15. [Antidiabetic efficacy of benfluorex. Clinical data].
Brun JM
Presse Med; 1992 Sep; 21(28):1344-52. PubMed ID: 1438105
[TBL] [Abstract][Full Text] [Related]
16. [Mode of action of benfluorex. Recent data].
Brindley DN
Presse Med; 1992 Sep; 21(28):1330-5. PubMed ID: 1438102
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for the effects of benfluorex on the obese-diabetic-dyslipidemic syndrome.
Brindley DN
Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():51S-56S. PubMed ID: 8299490
[No Abstract] [Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study of benfluorex in HIV-infected patients with insulin resistance or impaired glucose tolerance.
Poizot-Martin I; Drogoul-Vey MP; Di Stefano D; Jouve E; Fabre G; Saout A; Gastaut JA
HIV Clin Trials; 2009; 10(1):33-40. PubMed ID: 19362994
[TBL] [Abstract][Full Text] [Related]
19. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
[TBL] [Abstract][Full Text] [Related]
20. Acipimox in the treatment of patients with hyperlipidaemia: a double blind trial.
Ball MJ; Vella M; Rechlass JP; Jones DB; Stirling C; Mann JI; Galton D
Eur J Clin Pharmacol; 1986; 31(2):201-4. PubMed ID: 3803417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
